Attenuated ΔguaBA Salmonella typhi Vaccine Strain CVD 915 as a Live Vector Utilizing Prokaryotic or Eukaryotic Expression Systems to Deliver Foreign Antigens and Elicit Immune Responses
Marcela F. Pasetti(University of Maryland Global Campus), Marcelo B. Sztein(University of Maryland, Baltimore), Fernando Noriega(Novavax (United States)), Richard Anderson(University of Washington), Myron M. Levine(University of Maryland, Baltimore)
Cited by 66
Related Papers
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
|New England Journal of Medicine|2014|941
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls
|Infection and Immunity|2004|447
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
|Nature Reviews Microbiology|2007|372
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans
|Infection and Immunity|1997|251
Immunology of gut mucosal vaccines
|Immunological Reviews|2010|247